TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

AstraZeneca Gets 'Complete Response Letter' From FDA on Hyperkalaemia Treatment
MARKETS

AstraZeneca Gets 'Complete Response Letter' From FDA on Hyperkalaemia Treatment

Three Stocks Poised to Rally Off Double Moving Average Support
MARKETS

Relypsa (RLYP) Stock Downgraded to 'Hold' at Stifel

Zika Virus Gene Mutation May Cause Birth Defects
INVESTING

Biotech pop-up party in full swing

Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix
STOCKS

Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs

These 4 Stocks Could See Negative Catalysts From Earnings -- but What Do the Charts Say?
OPINION

4 stocks that could see negative catalysts from earnings, but what do the charts say?

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
INVESTING

Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal

Relypsa Stock Surges on $1.53 Billion Galenica Takeover Offer
VIDEO

Relypsa Stock Surges on $1.53 Billion Galenica Takeover Offer

Fibonacci Charts Suggest Short-Term Relief, but Long-Term Worries
INVESTING

Relypsa finally finds buyer, but potential seen for rival bid

FDA deals blow to Endo over Opana ER Pain Med
MARKETS

Relypsa (rlyp) stock surging on $1.5 billion acquisition by galencia

Alder BioPharmaceuticals: Cramer's Top Takeaways
MERGERS AND ACQUISITIONS

Galenica to buy Relypsa for $1.53B

5 Best-Positioned Biotech Stocks on Brexit Volatility
STOCKS

Biotech stocks pressured after the Brexit vote; here are 5 stock opportunities

Germany Slaps PTC Therapeutics With Big Drug Price Cut
STOCKS

Spurious Relypsa bear report built on unreliable data

5 ETFs to Buy If You Love Bank of America's First-Quarter Earnings
OPINION

7 stocks seeing big volume -- and how to trade them from here

NewLink Pancreatic Cancer Vaccine Fails, May Even Harm Patients
STOCKS

Relypsa Scores Big Win When Pharma Rival Flops at FDA

The War on High Blood Pressure Just Got Tougher to Win
MARKETS

Why Relypsa (RYLP) Stock is Surging Today

'Mad Money' Lightning Round: Energy Transfer Partners Is Going Higher
JIM CRAMER

'Mad Money' Lightning Round: You Don't Want to Touch UBS

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: These Stocks Still Sweet Despite Sour Market

Tobira Therapeutics (TBRA) Stock Surging After Allergan Deal
MARKETS

Here's Why Relypsa (RLYP) Stock Is Plunging Today

Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
MARKETS

Relypsa (RLYP) Stock Soars on Possible Sale

NxStage Medical Acquired by Fresenius for $2 Billion
STOCKS

Relypsa Fielding Takeout Offers, Shares Move Higher

'Mad Money' Lightning Round: Energy Transfer Partners Is Going Higher
JIM CRAMER

'Mad Money' Lightning Round: Take McDonald's Over Shake Shack

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Good Riddance to a Roller-Coaster Quarter

5 Things You Must Know Before the Market Opens Friday
OPINION

5 stocks insiders love right now.

Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix
STOCKS

Biotech Stock Mailbag: Acadia, Relypsa, Celator

'Mad Money' Lightning Round: Take Intuit Over H&R Block
JIM CRAMER

'Mad Money' Lightning Round: Palo Alto Networks Is Going Higher